The application of random forest-based models in prognostication of gastrointestinal tract malignancies: a systematic review
- PMID: 40756817
- PMCID: PMC12315591
- DOI: 10.3389/frai.2025.1517670
The application of random forest-based models in prognostication of gastrointestinal tract malignancies: a systematic review
Abstract
Introduction: Malignancies of the GI tract account for one-third of cancer-related deaths globally and more than 25% of all cancer diagnoses. The rising prevalence of GI tract malignancies and the shortcomings of existing treatment approaches highlight the need for better predictive prediction models. RF's machine-learning method can predict cancers by using numerous decision trees to locate, classify, and forecast data. This systematic study aims to assess how well RF models predict the prognosis of GI tract malignancies.
Methods: Following PRISMA criteria, we performed a systematic search in PubMed, Scopus, Google Scholar, and Web of Science until May 28, 2024. Studies used RF models to forecast the prognosis of GI tract malignancies, including esophageal, gastric, and colorectal cancers. The QUIPS approach was used to evaluate the quality of the included studies.
Results: Out of 1846 records, 86 studies met inclusion requirements; eight were disqualified. Numerous studies showed that when combining clinical, genetic, and pathological data, RF models were very accurate and dependable in predicting the prognosis of GI tract malignancies, responses, recurrence, survival rates, and metastatic risks, distinguishing between operable and inoperable tumors, and patient outcomes. RF models outperformed conventional prognostic techniques in terms of accuracy; several research studies reported prediction accuracies of over 80% in survival rate estimates.
Conclusion: RF models, in terms of accuracy, performed better than the conventional approaches and provided better capabilities for clinical decision-making. Such models can increase the life quality and survival of patients by personalizing their treatment regimens for cancers of the GI tract. These models can, in a significant manner, raise patients' survival and quality of life through hastening clinical decision-making and providing personalized treatment options.
Keywords: GI tract cancers; malignancy; prognose; prognostication; random forest.
Copyright © 2025 Mohamadi, Shafizadeh, Aliyan, Shayesteh, Goudarzi, Khodabandeh, Vaghari, Ashrafi, Bahrami, ZarinKhat, Khodabandeh and Pouyan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2. Cochrane Database Syst Rev. 2021. PMID: 34931303 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous